Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-01-06

Clinical Trial Update: Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of GLH8NDE for dry eye disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLH8NDE

Snippet

Sponsor: GL Pharm Tech Corporation | Conditions: Dry Eye Syndromes | Phase 2 | Status: UNKNOWN